Fierce Pharma

JULY 9, 2024

Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations. | Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team. And the division’s newly named commercial chief Christine Roth is among those changes.

Pharma 264

Pharma 264

MedCity News

JULY 9, 2024

A uniQure gene therapy for Huntington’s disease has interim clinical data showing an 80% slowing of disease progression. An accelerated approval pathway is one of the topics the company wants to discuss with the FDA. The post With New Huntington’s Gene Therapy Data, uniQure Hopes for Faster Path With FDA appeared first on MedCity News.

FDA 119

FDA Biopharma Pharma 119

Fierce Pharma

JULY 9, 2024

Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. | Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. House Speaker Mike Johnson has pledged to hold a vote for the controversial bill before the year is out.

248

248

MedCity News

JULY 9, 2024

Illinois, Kentucky, Oregon, Utah and Vermont have been authorized by HHS to provide Medicaid/Children’s Health Insurance Program coverage to those transitioning out of incarceration up to 90 days before they’re released. Several healthcare leaders called the action a necessary step. The post Health Leaders Applaud HHS’ Action Giving Some Incarcerated Individuals Medicaid Coverage Before Release appeared first on MedCity News.

Insurance 121

Insurance Healthcare Healthcare 121

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JULY 9, 2024

As Gilead Sciences tussles with a web of HIV drug litigation, a high-stakes case tied to patents for prevention medicines is coming back to test the drugmaker. | As Gilead Sciences tussles with a web of HIV med litigation, a case tied to patents for prevention regimens of Truvada and Descovy is not quite settled. Late last week, the U.S. government appealed Gilead's prior win in the fight.

Government 201

Government Medicine 201

Eversana Intouch

JULY 9, 2024

MM+M recently named Agios Pharmaceuticals’ “Do You See It?” campaign as their Campaign of the Week! The campaign focuses on the hidden dangers of thalassemia, a rare genetic condition affecting an estimated 8,000 Americans. The disease can result in anemia-like symptoms, with severe cases requiring regular blood transfusions, while milder cases often go untreated.

Pharmaceutical 105

Pharmaceutical Healthcare Provider Doctors Medical 105

European Pharmaceutical Review

JULY 9, 2024

Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The team tested various samples two ion chromatography analytical methods. This included a range of water types eg, purified and potable water, according to the paper. Kumar et al. explained that “accurate determination of nitrite content in process water will support an understanding of the potential for nitrosamine formation from nitrite in process water

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

Fierce Pharma

JULY 9, 2024

A storm of scrutiny relating to Johnson & Johnson’s pricing and patenting of its tuberculosis med bedaquiline (branded as Sirturo) is clearing up after reaching a fever pitch last year. | The country's antitrust authority opened a probe into J&J last year after it filed for a secondary patent on its tuberculosis drug. Now, authorities won't move forward with a complaint.

240

240

MedCity News

JULY 9, 2024

Here’s a look at three innovative software solutions that support healthcare transformation and are having a significant impact. The post Streamlining Healthcare: How Technology is Removing Friction for Providers appeared first on MedCity News.

Healthcare 102

Healthcare Healthcare 102

Fierce Pharma

JULY 9, 2024

Introduction | PhytoSquene® is the world’s first GMP-quality, plant-based squalene. Read this study to find out how it compares to shark-derived squalene.

131

131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

JULY 9, 2024

After languishing in the doldrums for a few quarters, there are signs that the winds of investment are starting to blow again in the US digital health sector.

104

104

PharmaVoice

JULY 9, 2024

Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.

112

112

pharmaphorum

JULY 9, 2024

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear. The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.

Prescription 94

Prescription Management Pharma Marketing 94

MedCity News

JULY 9, 2024

HarmonyCares raised $200 million dollars to scale its in-home primary care delivery model for high-risk senior patients. The money will be used to expand HarmonyCares’ market reach, particularly in the Medicare Advantage space — even as health systems continue to drop their MA contracts. The post HarmonyCares Snags $200M to Scale Its In-Home Primary Care Model For Medicare & MA Plans appeared first on MedCity News.

Marketing 95

Marketing Patients 95

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

JULY 9, 2024

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer

116

116

pharmaphorum

JULY 9, 2024

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.

Medical 79

Medical Pharmaceutical 79

PharmaTimes

JULY 9, 2024

The serious, progressive kidney disease affects nearly 850 million people worldwide

Medicine 113

Medicine 113

MedCity News

JULY 9, 2024

Achieving true national interoperability requires that all constituents have access to information that is trustworthy, accurate and presented in a way that is usable and actionable. The post The Healthcare Interoperability Road Trip – “Are We There Yet?” appeared first on MedCity News.

Healthcare 80

Healthcare Healthcare 80

Advertisement

pharmaphorum

JULY 9, 2024

Roche will reintroduce its Susvimo implant wet AMD, which was withdrawn from sale in 2022 due to manufacturing defects.

Manufacturing 92

Manufacturing Sales 92

MedCity News

JULY 9, 2024

In healthcare, a faulty algorithm can be a matter of life and death. The post Reining In the Wild West of AI appeared first on MedCity News.

Healthcare 91

Healthcare Healthcare Safety Patients 91

pharmaphorum

JULY 9, 2024

Mikael Dolsten exits Pfizer, putting R&D leadership in flux Phil.

95

95

Pharmaceutical Commerce

JULY 9, 2024

The latest news for pharma industry insiders.

Pharma 102

Pharma Patients 102

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaVoice

JULY 9, 2024

Recent history suggests an Alzheimer’s approval doesn’t necessarily translate to market triumph. Perhaps for Eli Lilly’s Kisunla, this time could be different.

Marketing 52

Marketing FDA 52

PharmExec

JULY 9, 2024

Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures.

FDA 52

FDA 52

Penrod

JULY 9, 2024

The full AHA Lawsuit order can be read here. The order follows years of criticism from the AHA, who viewed the bulletin as an overextension of executive power that prevented providers from serving their communities via online trackers that improved web experiences. However, the order was surprisingly narrow in scope. What does this mean for providers?

Healthcare 52

Healthcare Healthcare Healthcare Provider Networking 52

PharmExec

JULY 9, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, discusses results of the Femaseed pivotal trial, Fembloc birth control, and how the outcome of the 2024 United States presidential election could impact women's health.

52

52

Advertisement

Distribution

Pharmacy Times

JULY 9, 2024

In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.

Management 59

Management Prescription Leads Pharmaceutical 59

PharmExec

JULY 9, 2024

Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.

Medical 52

Medical Healthcare Healthcare Marketing 52

Pharmaceutical Technology

JULY 9, 2024

Moderna and Mitsubishi Tanabe have entered into a collaboration to jointly promote the former’s mRNA respiratory vaccine portfolio in Japan.

52

52

PharmExec

JULY 9, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, discusses results of the Femaseed pivotal trial, Femblock birth control, and how the outcome of the 2024 United States presidential election could impact women's health.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales